BIM
ACOR

Bogle Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Bogle Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,115
Closed -$1.03M – 347
2019
Q2 		$1.03M Hold
1,115
– – 0.08% 184
2019
Q1 		$1.78M Buy
+1,115
New +$2.01M 0.14% 151
2018
Q1 		– Sell
-2,079
Closed -$5.35M – 402
2017
Q4 		$5.35M Buy
+2,079
New +$5.91M 0.39% 92
2015
Q2 		– Sell
-856
Closed -$3.42M – 445
2015
Q1 		$3.42M Buy
856
+108
+14% +$495K 0.24% 119
2014
Q4 		$3.67M Buy
+748
New +$3.21M 0.24% 134

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogle Investment Management's ACOR Position: Q3 2019 in Review

Bogle Investment Management sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 1,115 shares — an estimated $1.03M sold.

Bogle Investment Management first reported a position in ACOR in Q4 2014 and held it in 5 quarters. The position peaked at $5.35M in Q4 2017. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

  • Bogle Investment Management reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Bogle Investment Management sold 1,115 Acorda Therapeutics shares in Q3 2019, an estimated $1.03M.
  • Bogle Investment Management first reported a position in Acorda Therapeutics in Q4 2014 and held it in 5 quarters.
  • Bogle Investment Management's Acorda Therapeutics position peaked at $5.35M in Q4 2017.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Bogle Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.